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The purpose of this study was to determine the outcome of men presenting with clinical breast problems for breast
imaging and to evaluate the role of mammography and ultrasound in the diagnosis of benign and malignant breast problems. We
retrospectively reviewed clinical, radiographic, and pathologic records of 165 consecutive symptomatic men presenting to Breast
Imaging over a 4 year period. We assessed the clinical indication for referral, mammographic findings, sonographic findings, his-
tologic results, and clinical outcomes. Patients ranged in age from 22 to 96 years. Breast Imaging Reporting and Data System
(BI-RADS) category 4 and 5 mammograms and solid sonographic masses were considered suspicious for malignancy. Six of 165
men (4%) had primary breast carcinoma, which were mammographically suspicious in all 6 (100%). Five were invasive ductal
carcinoma and one was ductal carcinoma in situ (DCIS). Of 164 mammograms, 20 (12%) were suspicious. Six were cancer and
14 were benign. Clinical follow-up for 2 years or biopsy results were available for 138 of the 165 men (84%). Twelve with benign
mammographic findings had benign biopsies. All men with benign mammography not undergoing biopsy were cancer free. Sen-
sitivity for cancer detection (mammography) was 100% and specificity was 90%. Positive predictive value (mammography) was
32% (6 of 19) and the negative predictive value was 100%. Sonography was performed in 68 of the 165 men (41%). Three of
three cancers (100%) were solid sonographic masses. There were 9 of 68 false-positive examinations (13%). Sensitivity and
negative predictive value for cancer detection (ultrasound) was 100% and specificity was 74%. The most common clinical indication
for referral was mass/thickening (56%). Mammography had excellent sensitivity and specificity for breast cancer detection and
should be included as the initial imaging examination of men with clinical breast problems. The negative predictive value of 100%
for mammography suggests that mammograms read as normal or negative need no further examination if the clinical findings
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n estimated 1450 new cases of male breast cancer will
be diagnosed in 2004 in the United States (1). Men
present with breast cancer at a later stage than women
(2–4). However, the majority of symptomatic men will have
benign abnormalities. Although most men with breast
cancer present with a subareolar mass (4,5), many men are
referred for breast imaging because of other less specific
clinical findings, such as tenderness or breast enlargement
(6,7). The algorithm for an accurate, cost-effective, and
painless diagnosis of male breast cancer remains to be
defined (5). Although the diagnostic accuracy of mam-
mography in men appears very good for cancer detection
(8), the literature is limited.
The purpose of our study was to determine the out-
come of men presenting with clinical breast problems for
breast imaging. We were especially interested in the role
of mammography and ultrasound in the diagnosis of men




Institutional Review Board approval was obtained
prior to commencement of the study. Individual patient
informed consent for this retrospective study was not
required. We retrospectively reviewed the clinical, radio-
graphic, and pathologic records of 166 consecutive symp-
tomatic men presenting to our Breast Imaging Section
from June 1996 to August 2000. We assessed the reason
for referral, mammographic findings, sonographic find-
ings, histologic results, and clinical outcomes. Excluded
was one man diagnosed with breast cancer at an outside
institution where original mammograms are unavailable
for review. In total, 165 breast imaging examinations
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were reviewed in 164 men. One hundred sixty-four
mammograms were performed in 163 men, and 1 had an
ultrasound only. One hundred forty-six had bilateral
mammograms and 18 had unilateral mammograms.
Patients ranged in age from 22 to 96 years, with a median
age of 64 years. The clinical presentation of men described
by the patient or the referring physician was recorded and
categorized into five groups: 1) a lump or mass, 2) tender-
ness or pain, 3) “gynecomastia” or breast enlargement, 4)
thickening, and 5) nipple discharge.
Mammograms performed at our institution were
performed using standard film screen techniques on
mammographic units (DMR General Electric Systems,
Milwaukee, WI). Standard examination included cranio-
caudal, mediolateral oblique, lateral, and spot compres-
sion views with metallic markers over the palpable areas
if a discrete lump was identified by breast examination
performed by our clinical breast examiners.
Mammograms were read by radiologists who were
Mammography Quality Standards Act (MQSA) certified.
In 2000, the range of experience was from 2 to 22 years
(mean 8.6 years). Breast Imaging Reporting and Data Sys-
tem (BI-RADS) (9) category assessments were recorded
for each mammographic examination based on the origi-
nal report. BI-RADS 1, 2, and 3 were negative, benign,
and probably benign, respectively; BI-RADS 4 and 5
were suspicious and highly suggestive of malignancy,
respectively.
Sonography was performed using high-resolution
ultrasound equipment (model 700, GE Medical Systems,
Milwaukee, WI; ATL HDI 5000, Philips, Bothell, WA)
with 7.5–13 MHz linear transducers and was exclusively
physician performed. Any discrete palpable lump or thick-
ening was sonographically evaluated at the discretion of
the radiologist. In patients who had both a mammogram
and ultrasound, the interpretations were performed by the
same radiologist at the same time. The sonographic find-
ings were categorized into three groups: (A) negative if no
discrete abnormality was found, (B) solid mass, or (C) cys-
tic mass. Although not available at the time of the study,
groups A and C correspond to the current American Col-
lege of Radiology Ultrasound BI-RADS categories 1–3
and group B to American College of Radiology Ultra-
sound BI-RADS (10) assessment 4 and 5.
The BI-RADS 4 and 5 mammographic assessments and
any solid sonographic mass were considered suspicious
for malignancy and recommended for biopsy. Mammog-
raphy BI-RADS categories 1–3 were considered negative.
Negative sonograms and simple cysts were considered
negative sonographic findings. Sensitivities, specificities,
positive predictive value (PPV), negative predictive value
(NPV), and accuracy for mammography and sonography
were performed.
Tissue diagnosis was obtained by open surgical biopsy
or fine-needle aspiration (FNA) and microscopic evalua-
tion was accepted as a definitive diagnosis. Tumor size,
axillary lymph node status, hormone receptor status, and
family history were recorded for men with carcinomas. If
no tissue diagnosis was obtained, clinical or image follow-
up was required for at least 2 years after the time of the
original complaint to be considered benign. Patients with
less than 2 years of documented follow-up were consid-
ered lost to follow-up. The data were entered into an Excel




The most common presentation was a mass or thick-
ening in 92 cases (56%). Tenderness or pain was described
in 50 cases (30%) (Table 1). Fourteen men (8%) presented
with “gynecomastia” or breast enlargement (Fig. 1) and
7 (4%) with nipple discharge. Two patients were referred
to breast imaging to evaluate breast findings noted on
chest computed tomography (CT); one after a motor vehicle
accident and the other after staging for lung cancer. There
was complete follow-up, either clinical or pathologic, in
138 cases (84%). Thirty-three men (20%) underwent
biopsy: 29 excisional biopsies and 4 FNAs. There were six
primary breast carcinomas (4%): one ductal carcinoma in
situ (DCIS) and five invasive ductal carcinomas. The size
of the cancers including the case of DCIS ranged between
1.6 cm and 3.5 cm (mean 2.4 cm). All carcinomas pre-
sented as a palpable mass or thickening.
Of the 144 men categorized as mammography BI-
RADS 1, 2, or 3, 118 (72%) had benign biopsies or benign
clinical follow-up (Table 2) and 26 (16%) were lost to
Table 1. Clinical Findings versus Outcomes in 165










Mass/thickening 6 20 52 14 92 (56%)
Gynecomastia/breast
enlargement
0 1 10 3 14 (8%)
Tenderness/pain 0 5 37 8 50 (30%)
Nipple discharge 0 1 4 2 7 (4%)
Other 0 0 2 0 2 (1%)








follow-up. Six of the 20 men (30%) categorized as
mammography BI-RADS 4 or 5 had biopsies positive
for malignancy (Fig. 2). One of the 20 (5%) was lost to
follow-up. No man categorized as mammography BI-
RADS 1, 2, or 3 had breast carcinoma. Pathologic results
for the 17 men categorized mammography BI-RADS
1–3 who underwent biopsy demonstrated gynecomastia
in 5, lipoma in 5, postoperative fluid collection in 1,
negative FNAs in 4, dermatophytoses in 1, and fibrocystic
change in 1.
Sonography was performed in 68 cases (41%). Forty-
eight of these (71%) were negative for a discrete mass, 19
(28%) demonstrated a solid mass, and 1 (1%) demon-
strated a cystic mass. Sixteen of the 68 men who had sono-
graphic evaluation were biopsied (24%): 45 (66%) had
benign follow-up and 7 (10%) were lost to follow-up
(Table 3). Eleven of the 16 that were biopsied (68%) had
a solid mass on ultrasound (Fig. 3) and 4 (25%) had
negative ultrasounds. Three men with solid masses on ultra-
sound had carcinoma. No carcinoma was found in men
with negative ultrasounds. There were nine false-positive
Table 2. Mammographic Assessment versus Clinical









1, 2 0 17 95 25 137 (84%)
3 0 1 5 1 7 (4%)
4, 5 6 9 4 1 20 (12%)
Total 6 (4%) 27 (16%) 104 (63%) 27 (16%) 164
Figure 1. Examples of a normal or fatty male breast and
gynecomastia. (a) A 57-year-old man with right nipple tenderness.
Right craniocaudal view mammogram demonstrates fatty parenchyma
without mass or other abnormality. Negative mammogram. (b) A 49-
year-old man presenting with left breast soreness and nodularity. Left
craniocaudal mammogram demonstrates retroareolar fibroglandular
tissue without a discrete mass consistent with gynecomastia, a benign
finding. Biopsy confirmed gynecomastia.
Figure 2. A 67-year-old man with a palpable, nontender, right breast
mass positive for adenocarcinoma. (a) Right craniocaudal view
mammogram demonstrates a round, spiculated, highly suspicious
retroareolar mass without associated calcifications. (b) Close-up
right lateral medial view mammogram of the retroareolar area
demonstrating the highly suspicious mass.
Table 3. Ultrasound Assessment versus Clinical









Negative 0 4 39 5 48 (71%)
Cystic mass 0 1 0 0 1 (1%)
Solid mass 3 8 6 2 19 (28%)
Total 3 (4%) 13 (19%) 45 (66%) 7 (10%) 68
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sonographic examinations (13%), including four gyneco-
mastia (Fig. 4), two lipomas, one sinusoidal hemangioma,
one postoperative fluid collection, and one benign FNA.
Of the eight men with abnormal ultrasound findings who
did not undergo biopsy (8 of 19; 42%), six had no further
breast complaints (including one patient with a lymph
node confirmed by ultrasound) after 2 years and two were
lost to follow-up (Table 3). The four men who had benign
biopsies and a negative ultrasound included three lipomas
and one gynecomastia.
Of the 54 men categorized as mammography BI-RADS
1, 2, or 3 and evaluated with ultrasound, 45 (83%) had
negative sonograms, 8 (15%) demonstrated a solid mass,
and 1 (2%) demonstrated a cystic mass (Table 4). In 13
men categorized as mammography BI-RADS 4 or 5, and
evaluated with ultrasound, 2 (15%) were sonographically
negative and 11 (85%) had sonographic masses (Table 4).
The single patient with sonographic evaluation only
revealed a solid mass. This was the patient treated for an
abscess that resolved. A single patient (6%) with gyneco-
mastia found on mammogram and categorized as BI-
RADS 4 demonstrated a solid sonographic mass, thus




Five of the six men (83%) with carcinoma had meta-
static disease in sampled axillary lymph nodes. The single
patient with negative sampled lymph nodes had papillary
DCIS. When hormone receptor status was available, four
(67%) were estrogen receptor (ER) positive, three (50%)
were progesterone receptor (PR) positive, one (17%) was









 negative. Two men had pos-
itive family histories for breast cancer and none were on
medications or had exposures to known causes of gyneco-
mastia. The median age of the men with breast carcinoma




The biopsy PPV for mammography was 32% (6/19);
the NPV was 100% (118/118). The sensitivity for cancer
detection was 100% (6/6) and the specificity was 90%
(118/131). The PPV for sonography was 17% (3/18); the
NPV was 100% (43/43). The sensitivity for cancer detec-
tion was 100% (3/3) and the specificity was 74% (43/58).
A palpable mass or thickening was the most sensitive
Figure 3. A 59-year-old man with a palpable left breast mass
with nipple retraction; biopsy-proven invasive ductal carcinoma.
(a) Left craniocaudal view mammogram demonstrating a retroareolar,
lobulated, highly suspicious mass with spiculated margins without
associated calcifications. (b) Ultrasound of the mass demonstrates a
solid, lobulated mass.
Figure 4. A 62-year-old man presenting with a palpable left breast
mass; excisional biopsy proven gynecomastia. (a) Left mediolateral
oblique view mammogram demonstrates a suspicious oblong
retroareolar mass without associated calcifications. (b) Ultrasound
with Doppler reveals a solid and vascular oblong retroareolar mass
with indistinct margins.
Table 4. Mammography versus Ultrasound in 67




Normal Solid mass Cystic mass Total
1, 2 42 7 1 50 (75%)
3 3 1 0 4 (6%)
4, 5 2 11 0 13 (19%)













The overwhelming majority of male breast problems
are benign (11,12) and include gynecomastia as one of the
most common male breast complaints (11,13). Although
rare and accounting for less than 1% of all breast cancers
(1), as in women, the incidence of breast carcinoma in
men has increased (2). Breast cancer in men must be
differentiated from benign clinical presentations. A later
stage of disease at presentation is seen more often in men
than in women (3,14). However, men and women have
equivalent prognoses when matched for age and stage of
disease (2,15). A proven appropriate algorithm for the
evaluation of male breast problems has not been defined.
FNA of palpable breast masses, together with physical
examination, has proven accurate (16,17). However,
FNA can misdiagnose malignancies in the male breast
(18). Evans et al. (8) found mammography alone has a
sensitivity and specificity of at least 90% and a negative
predictive value of 99%. Given the small number of car-
cinomas found in men, a low-cost, accurate diagnostic test
such as mammography could be an adjunctive tool to
physical examination (8). Also, there has been very little
in the literature on the role of ultrasound together with
mammography in evaluating breast problems in men.
The most common mammographic finding in our
series was gynecomastia, as in other reports (6–8). No
carcinoma was detected in men prospectively found to
have gynecomastia on mammography or a normal mam-
mogram, similar to a previous report (6). Gynecomastia
has been described to be coexistent with breast cancer and
obscuring it (8,12,19), but this was not found in our
population. All of the carcinomas in our series were ret-
roareolar spiculated masses without calcifications on
mammography. The mammographic assessment was pre-
dictive of clinical outcome. All malignancies were pro-
spectively identified by mammography, confirming the
high sensitivity of this modality.
Reports of ultrasound evaluation of male breast prob-
lems in the literature are limited, largely descriptive, and
have limited numbers (11,20–23). Ultrasound compli-
mented mammography in that the majority of sonograms
were normal in men with mammography BI-RADS cate-
gories 1–3, and the majority of sonograms demonstrated
solid masses in men with mammography BI-RADS cate-
gories 4 or 5. Ultrasound was found to successfully “down-
grade” 15% (2 of 13) of false-positive mammographic
cases (Table 4). No cancer was found in these cases if the
ultrasound was negative. Ultrasound was very sensitive in
our series, but lacked specificity.
In this series, men presented with a mass or thickening
as the most common complaint, followed by breast ten-
derness or pain. This was similar to other reports (6,11).
A mass or thickening was the most sensitive indicator for
breast carcinoma in our series, but lacked specificity, with
a PPV of 8%. Although some men with benign mammo-
graphic results were biopsied due to a high level of clinical
suspicion, clinicians appear to use imaging to decrease the
number of false-positive biopsies that would be generated
by physical examination alone. A mammogram is recom-
mended, given the high sensitivity of this modality, as the
initial imaging examination if the clinical examination is
not obvious. The NPV of 100% for mammography sug-
gests that mammograms read as normal or negative need
no further examination if the clinical findings are not sus-
picious. A normal ultrasound in these men confirmed the
NPV of a normal mammogram. We did not find any car-
cinomas sonographically that were not detected on mam-
mography. However, our series was too small to make a
definitive statement regarding the role of ultrasound in
male breast problems. Cases of carcinoma found by ultra-
sound that were obscured on mammography by gyneco-
mastia have been described (10,11). In women, it is the
standard of care to perform ultrasound in the evaluation
of a palpable abnormality without a discrete mammo-
graphic correlate (24), and it is likely prudent to do so
in men.
The mean size of the carcinomas was 2.4 cm, similar to
other series (2,11,19,20). The median age of 59 years of
men with breast carcinoma in our series was lower than
reported nationally (2,25), and is likely due to our patient
population and small sample size. All tumors were ductal
in origin, as predicted (2). The single case of DCIS was of
the papillary subtype, which has been described in more
than 75% of DCIS cases in men (26). One of the most
characteristic symptoms described for DCIS in men is
serosanguinous nipple discharge (26). However, our one
case of DCIS presented as a mass without nipple dis-
charge. A markedly higher proportion of men with breast
carcinoma have ER-positive tumors compared to women
(2). When receptor status was known, 67% were ER
positive compared to 90.6% nationally (2). All men with
invasive tumors were lymph node positive, consistent
with a higher rate of lymph node involvement at the time
of diagnosis compared to women (2).
There are several limitations to our study. Even though
our follow-up rate was reasonable, with 16% of men in
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this study lost to follow-up, our numbers remain small.
Sonographic evaluation was performed after mammogra-
phy and may have been influenced by the reader’s knowl-
edge of the mammogram. Also, we did not assess whether
the routine craniocaudal and mediolateral oblique views
are sufficient, and if the asymptomatic breast should also
be imaged. Imaging of the asymptomatic breast may prove
useful to assess for symmetry, but it has not been shown
to be routine for screening contralateral asymptomatic
breasts. We found no cases of bilateral breast cancer.
In conclusion, the imaging examination of men with
clinical breast problems should include mammography,
which appears to reduce the number of false-positive
biopsies and showed excellent sensitivity, similar to an
earlier report (8). Although the sensitivity of ultrasound
was excellent as well, but with lower specificity, our
numbers are too small to make a definitive recommendation
to exclude ultrasound in the diagnostic evaluation of
men with breast problems. As in women, ultrasound
may be used to evaluate palpable abnormalities in men,
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